Travel Costs Are Considerable Part of T2DM Follow-Up Costs

FRIDAY, July 6, 2018 -- For patients with type 2 diabetes mellitus (T2DM), travel costs relating to hemoglobin A1c (HbA1c) screening constitute a substantial cost item, and self-monitoring can reduce costs, according to a study published in the July...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news